NGF and bone cancer: This pathological sprouting of nerve fibres was attributed to the actions of nerve growth factor (NGF), and sustained inhibition of NGF, either via administration of anti-NGF or a Pan-Trk inhibitor, markedly attenuated nerve sprouting, neuroma formation and bone pain even in advanced stages of bone cancer [36, 57].